Offer - Urjas Oil for just ₹ 1 X
Nebiring 2.5 Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of High BP.
The correct dosage of Nebiring 2.5 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Nebiring 2.5 Tablet can also lead to other problems, which have been listed below. Such side effects of Nebiring 2.5 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Nebiring 2.5 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. It is important to know if Nebiring 2.5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Nebiring 2.5 Tablet related warnings section.
Individuals suffering from medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Nebiring 2.5 Tablet since this can cause severe adverse effects. The section on Nebiring 2.5 Tablet contraindications lists all such conditions.
Drug interactions for Nebiring 2.5 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Nebiring 2.5 Tablet is not safe while driving, and is is not addictive in nature.
Nebiring 2.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebiring 2.5 Tablet safe for pregnant women?
Nebiring can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Nebiring 2.5 Tablet safe during breastfeeding?
Taking Nebiring may lead to serious side effects if you are breastfeeding. Nebiring should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Nebiring 2.5 Tablet on the Kidneys?
Nebiring rarely affects the kidneys.
What is the effect of Nebiring 2.5 Tablet on the Liver?
Side effects of Nebiring rarely affect the liver.
What is the effect of Nebiring 2.5 Tablet on the Heart?
Side effects of Nebiring rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Nebiring 2.5 Tablet unless your doctor advises you to do so -
Is this Nebiring 2.5 Tablet habit forming or addictive?
Nebiring 2.5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nebiring 2.5 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Nebiring 2.5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Nebiring 2.5 Tablet for mental disorders.
Interaction between Food and Nebiring 2.5 Tablet
Taking Nebiring 2.5 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Nebiring 2.5 Tablet
Taking Nebiring 2.5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897